Mr. Harrison Aaron reports

CRONOS ANNOUNCES EXTENSION OF SHARE REPURCHASE PROGRAM TO THE TORONTO STOCK EXCHANGE

Cronos Group Inc. has filed with the Toronto Stock Exchange, and the TSX has accepted, the company's notice of intention to make a normal course issuer bid (the TSX NCIB).

As previously announced by Cronos, the company's board approved a share repurchase program on May 8, 2026, which commenced on May 14, 2026, and is expected to terminate on May 13, 2027, unless earlier terminated. Pursuant to the TSX NCIB, repurchases under the share repurchase program may now also be made from time to time pursuant to the facilities of the TSX and other alternative Canadian trading systems, in addition to being made through open market purchases at then-prevailing market prices through the facilities of the Nasdaq Global Market or other U.S. published markets, privately negotiated transactions or otherwise, as previously announced. Pursuant to the share purchase agreement entered into on May 14, 2026, Celadon Financial Group LLC has been appointed as the company's agent to repurchase shares on its behalf. Any such repurchases will be executed through Virtu Canada Corp. when made over the facilities of the TSX or other alternative Canadian trading systems

Pursuant to the share repurchase program (including the TSX NCIB), Cronos intends to purchase for cancellation up to $50-million (U.S.) of common shares in the capital of the company (in any case subject to a maximum of 18,712,918 common shares, representing approximately 5.02 per cent of Cronos's 373 million issued and outstanding common shares as at June 1, 2026).

Under the TSX NCIB, Cronos may purchase up to 53,968 of its common shares on the TSX during any trading day, representing 25 per cent of the average daily trading volume of 215,873 common shares on the TSX for the six months ended May 31, 2026, other than block purchase exemptions. Purchases under the TSX NCIB may commence on June 19, 2026, and continue until the date on which the share repurchase program terminates as noted above.

The TSX NCIB will be conducted in accordance with TSX rules and policies through the facilities of the TSX. The price that Cronos will pay for any common shares will be the market price prevailing at the time of purchase or such other price as may be permitted.

Additionally, on June 15, 2026, Cronos obtained an exemption order from the Ontario Securities Commission, permitting Cronos to make repurchases under the share repurchase program through the facilities of the Nasdaq and other United States-based trading systems in excess of the maximum that would otherwise be allowable under applicable Canadian securities laws absent an exemption. The NCIB exemption allows Cronos to repurchase on such U.S. marketplaces up to the greater of 5 per cent of Cronos's outstanding shares and 10 per cent of Cronos's public float, provided that Cronos's aggregate repurchases on all marketplaces do not exceed this amount over the approximately 11-month period of the TSX NCIB, which is consistent with the maximum number of shares Cronos is able to purchase under the TSX NCIB. The other conditions to the NCIB exemption will be outlined in Cronos's quarterly report on Form 10-Q for the quarter ended June 30, 2026, filed on EDGAR and SEDAR+.

About Cronos Group Inc.

Cronos is a global cannabis company focused on scaling leading consumer goods products through research and development and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos's diverse international brand portfolio includes Spinach, Peace Naturals, Lit and Lord Jones.

We seek Safe Harbor.